Elmar Kirches
Magdeburg, ST, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Life and death of molecular subclones in recurrent meningioma: A case study.
Journal: Clinical neuropathology
Published: May 16, 2022
A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
Journal: Brain pathology (Zurich, Switzerland)
Published: September 14, 2021
AKT1E17K -mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363.
Journal: Neuropathology and applied neurobiology
Published: August 03, 2021
Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases.
Journal: Clinical neurology and neurosurgery
Published: June 23, 2021
Crispr/Cas-based modeling of NF2 loss in meningioma cells.
Journal: Journal of neuroscience methods
Published: February 09, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.
Journal: Acta neuropathologica
Published: July 29, 2020
KLF4K409Q-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment.
Journal: Acta neuropathologica communications
Published: January 14, 2020
Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
Journal: Journal of the neurological sciences
Published: September 23, 2019
Mitoferrin-1 is required for brain energy metabolism and hippocampus-dependent memory.
Journal: Neuroscience letters
Published: August 07, 2019
Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells.
Journal: Journal of neuro-oncology
Published: October 20, 2017
Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.
Journal: Journal of the neurological sciences
Published: June 14, 2017
Last Updated: 09/26/2026